Heranba Industries Limited Cash Flow Conversion Efficiency

Latest as of September 2023: 0.015x

Heranba Industries Limited cash flow conversion efficiency. Based on the latest financial reports, Heranba Industries Limited (HERANBA) has a cash flow conversion efficiency ratio of 0.015x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs123.60 Million ≈ $1.34 Million USD) by net assets (Rs8.27 Billion ≈ $89.41 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Heranba Industries Limited (2014–2025)

Cash flow conversion efficiency of Heranba Industries Limited from 2014 to 2025. This chart illustrates how Heranba Industries Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View HERANBA share price today for real-time trading data and today's change.

Heranba Industries Limited Cash Flow Conversion Ratio Explained

Heranba Industries Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Heranba Industries Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heranba Industries Limited ranked by their cash flow conversion efficiency. Also see market value of Heranba Industries Limited for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Thorney Opportunities Ltd
AU:TOP
0.039x
Wspierania Przedsiebiorczosci
WAR:PTW
0.003x
Great Elm Group Inc
NASDAQ:GEG
0.101x
DKME Co., Ltd.
KO:015590
-0.053x
Titanium Oyj
HE:TITAN
0.222x
Games Workshop Group PLC
LSE:GAW
0.512x
Viet Nam Fumigation JSC
VN:VFG
-0.243x
ADVENICA AB
F:65R
0.083x

Annual Cash Flow Conversion Efficiency for Heranba Industries Limited (2014–2025)

The table below shows the annual cash flow conversion efficiency of Heranba Industries Limited from 2014 to 2025. Review Heranba Industries Limited free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs8.50 Billion
≈ $91.92 Million
Rs1.01 Billion
≈ $10.96 Million
0.119x -5.16%
2024-03-31 Rs8.53 Billion
≈ $92.26 Million
Rs1.07 Billion
≈ $11.59 Million
0.126x -16.87%
2023-03-31 Rs8.10 Billion
≈ $87.64 Million
Rs1.23 Billion
≈ $13.25 Million
0.151x +10.01%
2022-03-31 Rs7.14 Billion
≈ $77.27 Million
Rs981.75 Million
≈ $10.62 Million
0.137x +20.15%
2021-03-31 Rs5.28 Billion
≈ $57.12 Million
Rs603.99 Million
≈ $6.53 Million
0.114x -32.31%
2020-03-31 Rs3.21 Billion
≈ $34.70 Million
Rs542.11 Million
≈ $5.86 Million
0.169x -55.86%
2019-03-31 Rs2.29 Billion
≈ $24.78 Million
Rs877.02 Million
≈ $9.48 Million
0.383x +16.14%
2018-03-31 Rs1.58 Billion
≈ $17.04 Million
Rs519.47 Million
≈ $5.62 Million
0.330x +21.99%
2017-03-31 Rs1.16 Billion
≈ $12.54 Million
Rs313.19 Million
≈ $3.39 Million
0.270x +62.42%
2016-03-31 Rs991.25 Million
≈ $10.72 Million
Rs164.90 Million
≈ $1.78 Million
0.166x -16.74%
2015-03-31 Rs851.11 Million
≈ $9.20 Million
Rs170.05 Million
≈ $1.84 Million
0.200x -49.40%
2014-03-31 Rs611.06 Million
≈ $6.61 Million
Rs241.26 Million
≈ $2.61 Million
0.395x --

About Heranba Industries Limited

NSE:HERANBA India Agricultural Inputs
Market Cap
$63.88 Million
Rs5.91 Billion INR
Market Cap Rank
#20774 Global
#1141 in India
Share Price
Rs147.63
Change (1 day)
+1.81%
52-Week Range
Rs145.01 - Rs295.30
All Time High
Rs833.08
About

Heranba Industries Limited manufactures and sells various agrochemicals in India and internationally. It offers intermediates, such as cypermethric acid chloride (CMAC), high CIS CMA and CMAC, high trans CMA and CMAC, bromobenzenes, metaphenoxy benzaldehyde and benzyl alcohol, and NPBR; and insecticides, including cypermethrin, deltamethrin, alpha cypermethrin, tolfenpyrad, lambda cyhalothrin, pe… Read more